In this episode, we delve into the world of AI-powered healthcare with Shayan Mashatian, the founder of Pingoo.AI. You can learn how this innovative startup is applying AI to tackle a critical healthcare challenge: diabetic foot ulcers.Shayan highlights the alarming statistics surrounding diabetes and its complications, emphasizing the need for greatly improved patient education and engagement. Pingoo.AI's solution leverages AI to provide personalized education and support for patients, helping them understand their condition and manage it effectively.Shayan also shares how collaboration between healthcare providers, innovators, and patients, is leading to better AI integration and use of data. By leveraging technology and fostering a community-driven approach, the Pingoo.AI team is working towards a future where diabetes and its complications are better managed and ultimately prevented, a mission sure to leave you informed and inspired.

Novobeing is addressing a significant problem in healthcare: poor patient experience during hospital stays. Their solution involves using virtual reality technology to transport patients to calming environments, helping to reduce stress and anxiety. Beyond the direct benefits to patients, this also aims to improve HCAHPS (Hospital Consumer Assessment of Healthcare Providers and Systems) scores, as patient satisfaction increases.CEO and co-founder, Sid Desai, shares how their research studies are validating these benefits for hospitals systems, with exciting recent results from Massachusetts General Hospital providing further evidence. The company's initial focus is on patients undergoing stem cell transplant procedures, who often face prolonged hospital stays and isolation. Novobeing’s VR technology offers a way to improve their mental well-being and overall experience.With several hospital systems already testing Novobeing’s solution, Sid discusses the exciting opportunities, including the potential to reduce pharmacological interventions. As the healthcare industry embraces Medical VR, the vision of fully patient-centered care comes closer to reality. Novobeing is well placed to play a central role in this evolution, meaning this story is sure to leave you informed and inspired.

Prapela is a medical device company focused on improving newborn health. Their primary product is a specially designed mattress that uses gentle vibrations to regulate infant breathing, particularly for babies experiencing apnea of prematurity and neonatal opioid withdrawal syndrome.CEO & co-founder, John Konsin, joins this episode to share how many newborns, especially premature babies, experience breathing irregularities, including apnea and oxygen desaturation. Prapela's innovative mattress offers a non-invasive solution than can reduce the need for additional interventions while lowering costs for hospitals.Prapela's market potential is significant, as it addresses a common and serious issue affecting newborn infants. Building on decades of research and recent exciting clinical evidence, the Prapela journey is definitely one to track, be sure to tune in so you can be informed and inspired.

Millions of men suffer from premature (early) ejaculation, the most common sexual disorder in men younger than 40 years, with 30-70% of males in the United States affected to some degree at one time or another. This can be a major relationship issue for both partners and is often viewed as a challenging matter to discuss. Coupled with this, existing treatments like sprays, creams, and antidepressants have side effects or are found to be not very effective.Morari Medical’s CEO and Founder, Jeff Bennett, joins this episode to share how they are developing a wearable patch that uses neurostimulation to delay ejaculation. The patch is placed on the perineum, the area between the scrotum and the anus, and users can control the settings through an app to find what works best for them.As Morari gears up for FDA approval and aims to be on the market in early 2025, Jeff discusses how he has transitioned from working at Boston Scientific to leading not just a startup, but a movement to make premature ejaculation no longer a taboo topic. From being spotlighted on Jimmy Kimmel, to winning numerous accolades, Jeff’s story will be sure to leave you informed and inspired.

For episode 60, and one of the most popular recordings to date, we re-release the very first episode of the show where Rajit Kamal, currently VP & General Manager of Medtronic's Surgical Robotics division, joined us to talk about early-stage innovation.This is a must listen for any medtech entrepreneur as Rajit discusses how large medtech companies approach innovation and what they look for in early-stage startups. Rajit shares insights from his years of experience in the industry, developing winning teams, and how to overcome challenges bringing new solutions to patients. Be sure to tune in so you can be informed and inspired.

Jhonatan Bringas Dimitriades MD, CEO and co-founder of Lapsi Health, joins this episode to share insights into the company's newly launched product, Keikku—a revolutionary digital stethoscope designed to enhance the detection and monitoring of health conditions through advanced acoustic processing. Jhonatan discusses how Keikku is transforming traditional stethoscopes from simple listening devices into powerful data-driven tools that support medical diagnosis and patient monitoring. Initially targeting general healthcare professionals, Keikku is a part of Lapsi's broader vision to revolutionize health tracking. The stethoscope allows healthcare professionals to stream real-time sound clips and communicate securely, enabling faster and more accurate medical insights. Future software updates will incorporate AI-driven analysis for heart murmur detection and respiratory issues like wheezing, positioning Keikku at the forefront of smart medical devices. Throughout the discussion, Jhonatan emphasizes Lapsi Health's mission to make cutting-edge medtech more accessible and user-friendly for healthcare professionals and patients alike. With FDA clearance for Keikku already secured and additional approvals for AI features in the pipeline, the Lapsi team has a clear vision to position their hardware and software platform to help reshape how doctors and patients engage with medical technology. Listen in so you can be informed and inspired.

When you’re talking to one the founding fathers of pulse field ablation, you know you’re in for a real whirlwind of wisdom. Dr. Steven Mickelsen is a board-certified electrophysiologist who invented a pulsed electric field system and founded FARAPULSE in 2012. Ten years later, he is back at it again, with the founding of Field Medical Inc., as he looks to continue the crusade for superior cardiac ablation procedures.This discussion delves deep into the anatomical anomalies that ablation looks to tackle. Steven masterfully guides through the depths of the heart’s chambers and the limitations of today’s techniques. Through reverse engineering the problem, Field Medical is bringing new possibilities to tackling the underserved space of ventricular arrhythmia ablation.From the outset, Steven’s knowledge makes this a truly insightful summary of all things pulsed field ablation related, with a good sprinkling of entrepreneurial sagacity. Nearly every innovative startup hones in on a true unmet need to get started, and Field Medical’s blue ocean opportunity in VT makes this episode one that will be sure to leave you informed and inspired.

Kristin Nuckols, co-Founder & Chief Clinical Officer of Imago Rehab, joins this episode to discuss the challenges and opportunities in stroke rehabilitation. She highlights the increasing incidence of stroke and the devastating impact it can have on survivors and their families. She shares the challenges faced by healthcare providers in delivering effective post-stroke care, particularly in resource-limited settings.Kristin provides insights into her extensive experience as an Occupational Therapist and time in the Harvard Biodesign program that has allowed her to build a unique understanding of how high-quality rehabilitation for stroke survivors can improve their physical, cognitive, and emotional outcomes. Despite the numerous benefits of rehab, the growing number of patients mean new flexible solutions are essential to ensure the right care is available.Imago Rehab is developing innovative solutions to address these challenges, with a focus on making high-quality rehabilitation accessible to anyone recovering from a stroke. If you want to learn how soft robotics is being coupled with telemedicine to build a better future, then tune so you can be informed and inspired.

Millions of patients develop pressure injuries (bed sores) every year, often due to a lack of early detection. These wounds can lead to serious complications and even death. The current method of diagnosis relies on visual inspection by healthcare providers, which can be subjective and unreliable.Sanna Gaspard, CEO & Founder of Rubitection, joins this episode to discuss how she is developing a low-cost, easy-to-use medical device that uses optics to measure skin redness and inflammation, providing objective data for early detection of pressure injuries. The device is accompanied by a mobile app that allows clinicians to track changes in the wound, receive care recommendations, and capture images.Sanna shares insights around Rubitection’s functional prototype that has shown positive results in initial human testing. Access is a key word throughout the episode, and this includes how the company is utilizing Wefunder to crowdfund the capital needed to advance the technology and ensure that the community can access investing in the venture.  Packed with impactful goals for patients, this story is sure to leave you informed and inspired.Be sure to join us on September 25-26 at MEDevice Boston where you can hear from other innovators leading the charge to help improve patient lives (use the code IMPACT to get your free expo pass and 20% conference ticket discount at the checkout).

Augie Shanahan, CEO of Piccolo Medical, joins this episode to discuss the challenges and opportunities in the field of central venous catheter placement. He highlights the limitations of current Peripherally inserted central catheter (PICC) technologies and the need for more accurate and reliable navigation methods.Piccolo Medical is developing innovative solutions to address these challenges, including their proprietary ionic dilution technology that provides real-time blood flow visualization. This technology has the potential to improve the accuracy and safety of catheter placement, especially in patients with arrhythmias.Augie shares insights into the company's journey, from its origins as a spin-out from the TheraNova incubator to its recent FDA clearance for the Easy Guide Connector. As an engineer turned CEO, Augie has plenty of great perspectives of the numerous challenges in successfully developing a novel medical, insights sure to leave you informed and inspired.Be sure to join us on September 25-26 at MEDevice Boston where you can hear from other innovators leading the charge to help improve patient lives (use the code IMPACT to get your free expo pass and 20% conference ticket discount at the checkout).

Chris Landon, CEO of Natus Neuro, joins us to discuss the challenges and opportunities in neurodiagnostics. Six months since being appointed, Chris shares a clear vision for Natus as he explains the need for improved access to diagnostic tools and the importance of data-driven insights for better patient care.Chris emphasizes the role of technology in addressing these challenges, including artificial intelligence and cloud-based solutions. A focus on patient-centric innovation is a recurring theme throughout the episode as Chris details their commitment to developing solutions that improve clinical workflows and patient outcomes.From winning principles in product development, to developing a global strategy with a new team, this conversation is a fantastic insight into how Chris is leading the Natus vision. If you want to learn about the latest neuro sensor trends, and how to execute a winning game plan to address these, then be sure to tune in so you can be informed and inspired.Be sure to join us on September 25-26 at MEDevice Boston where you can hear from other innovators leading the charge to help improve patient lives (use the code IMPACT to get your free expo pass and 20% conference ticket discount at the checkout).

Sydney Robinson, CEO & co-founder of Vessl Prosthetics, joins this episode to discuss how they are enhancing prosthetic technology. Her innovative company is developing an advanced prosthetic socket that can offer unparalleled comfort, mobility, and functionality for amputees.During the discussion, Sydney shares her personal journey and the critical medical innovation fellowship that led to the founding of Vessl Prosthetics. She discusses the challenges faced by amputees and the limitations of traditional prosthetic solutions. Vessl's mission is to address these shortfalls by providing truly accessible and customized solutions that improve the quality of life for users.We dive into the company's research and development efforts to reach these goals, including collaborating with Stevie Crawford as he trains for the 2026 Winter Paralympics. Sydney also shares insights into the latest advancements in prosthetic technology and the potential for future partnerships. As the company prepares for FDA approval, strap in and listen, so you can be informed and inspired.Be sure to join us on September 25-26 at MEDevice Boston where you can hear from other innovators leading the charge to help improve patient lives (use the code IMPACT to get your free expo pass and 20% conference ticket discount at the checkout).

SmartCardia is a medical technology company developing innovative solutions to improve cardiac care. The company's flagship product is a 7-lead ECG patch that collects vital signs and enables remote patient monitoring. This technology addresses the limitations of traditional ECG patches by providing more comprehensive data and facilitating real-time monitoring. Adam Kirchgessner, VP of Sales at SmartCardia, joins this episode to discuss the company's mission and technology. He highlights how they are helping provide accurate and accessible cardiac data for early detection and diagnosis of arrhythmias and other heart conditions. Adam also explains the significant value prop of their advanced platform that enables seamless data integration and analysis, empowering healthcare providers to make informed decisions. Beyond ECG monitoring, the company's goal is to become a comprehensive cardiac care solution, offering remote patient monitoring for conditions like heart failure and sleep apnea. Adam delves into what goes into building a winning sales team to achieve these ambitions, touching on his extended experience with other innovative technologies. Whatever your position in the medical technology space, this episode is packed with insights on delivering great innovation, a discussion sure to leave you informed and inspired. Be sure to join us on September 25-26 at MEDevice Boston where you can hear from other innovators leading the charge to help improve patient lives (use the code IMPACT to get your free expo pass and 20% conference ticket discount at the checkout).

For our 50th episode, we are joined by Mike Hugo, a patient advocate for Medtronic, who shares the story behind his battle with glioblastoma, a highly aggressive form of brain cancer. Mike's unique perspective as both a patient and industry insider offer valuable insights into the challenges and triumphs of navigating a complex medical condition. The discussion delves into Mike's journey, from initial diagnosis to experiences with a unique treatment pathway, and the impact of Novocure's incredible Optune technology that he wears every day. Mike's unwavering determination and positive outlook shine through as he explains his advocacy efforts, including supporting the Promising Pathway Act, to improve access to these types of advanced treatments for other patients. Beyond his personal story, Mike offers valuable insights into the medtech industry, sharing former experiences as a medtech sales professional and his passion for driving innovation in patient care. His firsthand knowledge of medical devices and advocacy work with his wife Vanessa, highlight the importance of collaboration between patients, healthcare providers, and industry leaders in advancing healthcare solutions. Listen in, and be prepared, to be truly, inspired and informed. Be sure to join us on September 25-26 at MEDevice Boston where you can hear from other innovators leading the charge to help improve patient lives (use the code IMPACT to get your 20% discount at the checkout).

After a needlestick injury, Dr. William Travis Lau conceived a safety suturing device to protect other healthcare workers from suffering a similar incident. Partnering with Joe Lane to help create what would become SafePath Medical, they started development of the first safety suturing device for catheter securement. Though Travis tragically passed away in 2019, his legacy endures through this life-saving innovation and his contributions to patient safety and blood management practices. SafePath’s CEO Joe, joins this episode to share insights into the unique design challenges that have been overcome to realize Travis’s vision, and create an ergonomic device that is capable of safe suturing for catheter securement and skin closure. With FDA clearance already in place for the intended use in placement of a silk suture in the skin and subcutaneous tissues, Joe discusses the multiple benefits that can now be made available to healthcare workers. This physician-backed solution is packed with engineering ingenuity and Joe shares how M2D2 is entwined in the backstory that helped the startup move from prototype to marketplace, leaving it primed to revamp the current standard of care. Under Joe’s leadership, SafePath Medical is realizing not only Travis’s vision, but a safer future for frontline healthcare workers. This is a true legacy story that is sure to leave you informed and inspired.

As a global leader in medical technologies, Stryker provides a wide range of innovative products to help improve patient and healthcare outcomes. With over 50,000 employees around the world working together to serve more than 150M patients annually, delivering a compliance driven culture is critical to the success of the business. Ultimately, whatever the size of your medtech organization, managing compliance risk means managing business risk. Dana McMahon, Chief Compliance Officer at Styker, joins this episode to share how she is collaborating with colleagues to ensure the organization has the mindset and tools needed to position multibillion-dollar projects for successful commercialization, profitable growth, and compliant operations across the value chain.  To cultivate a culture that moves past a tick box approach to compliance, Dana discusses how they have developed a structure that offers multiple touch points and brings elements of fun to engage employees. She highlights how their Code of Conduct refresh and launch campaign was awarded Stryker’s Brand Implementation of the Year award at the Marketing Excellence Awards, a first for a functional team! With a thriving share price, Stryker’s efforts around compliance are entwined with their growth over the past five years. If you’re looking to learn from the best about what it takes to achieve this winning culture, and create real impact, then be sure to tune in so you can be informed and inspired.

Imricor Medical Systems is advancing the electrophysiology field by allowing physicians to perform cardiac ablation procedures in the growing number of interventional magnetic resonance (iCMR) suites found or being developed in leading hospitals. In this episode, we are joined by Imricor’s Global Sales Leader, Greg Englehardt, to share the journey and their mission of bringing not just a set of innovative surgical tools to market, but also an entirely new operating environment! Where other large companies have tried and failed, Greg details how the company has navigated an array of technical challenges to make their solution successful. Between gaining Imricor’s CE mark approval and navigating a product launch during the pandemic, combined with Greg’s extensive experience with startups, this discussion is packed with insights. If you want to learn more about their upcoming US market development and how you could be part of a growing team then be sure to tune in so you can be informed and inspired.

Deep brain stimulation (DBS) is a neurosurgical procedure that treats neurological conditions by implanting electrodes into the brain to produce electrical impulses. These impulses can control abnormal brain activity and chemical imbalances that cause conditions like Parkinson's disease, essential tremor, and dystonia. Despite the benefits of DBS, less than 1% of the 25 million patients who are eligible to undergo the procedure opt-in due to the invasiveness of and risk associated with traditional open brain surgery. Nicky Driscoll, CTO of NeuroBionics, joins this episode to share how their team is on a mission to change the status quo through bioelectronic medicine. NeuroBionics is developing devices that seamlessly integrate with the human body and aim to offer DBS with a minimally-invasive approach. As well as learning about this exciting technology, Nicky shares insights into the journey from academic researcher to entrepreneur, and how they decided to focus on a challenging commercialization journey that could positively impact patient lives. As one of the top startups in the M2D2 accelerator program and recent winners of the 2024 Vision Award with Medtech Innovator, the NeuroBionics story is definitely one to follow, and is sure to leave you informed and inspired.

Amplitude Vascular Systems (AVS) is a medical device company based in Boston, MA, focused on safely and effectively treating severely calcified arterial disease. AVS is backed by global investors including BioStar Capital and Cue Growth Partners to develop their innovative Pulse IVL System that has recently received an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to begin its pivotal trial.Angie Volk, VP of Business Development, and Sean Gilligan, COO of AVS, join this episode to share about their team’s mission and how they are bringing this exciting technology to market. With Johnson & Johnson’s $13.3B acquisition earlier this year of Shockwave Medical, the IVL space is showing that it is currently one of the hottest spaces in medtech. We discuss how AVS’s Pulse IVL System is being designed to easily deliver therapy across complex calcified lesions and reduce overall procedural costs, making it hugely attractive to potential future acquirers.  As former Boston Scientific colleagues, Angie and Sean have extensive industry experience including unique insights of building a winning culture, and they are leveraging these learnings and their network to efficiently navigate their solution to patients across the globe. With two medtech veterans, this is a conversation brimming with helpful tips for any would-be entrepreneur that is sure to leave you informed and inspired.

The Future Health Index (FHI) survey conducted by Philips, a global leader in health technology, explores the challenges within healthcare systems and the innovative solutions being used to address them. From the survey findings, the recently released ninth annual report - 'Better Care for More People', demonstrates the pressures of staffing shortages and burnout on clinicians, and their ability to deliver timely, high-quality care to patients.  Jeff DiLullo, Chief Region Leader for Philips North America, joins this episode to discuss the findings and share how Philips is utilizing collaborative innovation to address the challenges. Jeff highlights the investments that healthcare leaders are making to help ease the burden on staff, such as automation and artificial intelligence, and those that are having an impact on increasing access and health equity such as virtual care.  Technology adoption is no longer a choice, but an imperative that leaders like Jeff are working with the community to bring solutions to where they are needed most. From AI to telehealth and virtual care, this conversation is a calling card to those who want to work together to foster innovation. Listen in for some wonderful takeaways from Jeff, and be sure to check out the Future Health Index 2024 Report so you can be informed and inspired.

Strokes are caused by blocked blood flow to the brain (ischemic stroke) or sudden bleeding in the brain (hemorrhagic stroke). About 87% of strokes are ischemic with the blockage in the brain usually caused by a piece of plaque or a blood clot. Like fingerprints, no two strokes are the same. Yet, conventional therapy options are limited and can compromise patient safety.​​ Rapid Medical’s CEO and co-founder, Ronen Eckhouse joins this episode to share how they are bringing critical innovation to tackle ischemic strokes and enable physicians to respond in real-time to the brain’s complex anatomy, helping tailor the procedure to every patient. Rapid Medical’s uniquely designed stent is hard on the clot but soft on the vessel, this allows physicians to actively adapt to the fragile environment found in the brain. Ronen shares how the company has built value through strong partnerships, a growing patent portfolio, and ultimately helped bring enhanced outcomes for stroke patients in countries across the globe. With a long-term mission to solve big problems and some exciting new innovation on the horizon, Ronen’s journey is one sure to leave you informed and inspired.

Vasectomy is a form of male birth control that cuts the supply of sperm to semen by cutting and sealing the tubes that carry sperm. The procedure has a low risk of problems and can usually be performed in an outpatient setting under local anesthesia. Despite contraceptive use worldwide increasing by 188 million users in the past 20 years, the number of vasectomy users fell by 27 million, a 61% decline, with almost all low-and-middle income countries reporting negligible vasectomy use. Female-to-male disparities in permanent method use have also widened further in the same period.Joining this episode, Signati Medical’s CEO and Founder William ‘Billy’ Prentice, shares how their company is dedicated to advancing men’s health and changing the status quo. Signati plans to launch the first innovation in vasectomy in more than 20 years with a procedure that would be fast for physicians and comfortable for patients. Designed to take just minutes, this could be done right in the urologist’s office and would offer easier recovery compared to some current techniques.From the get-go, Billy’s drive and motivation to advance the accessibility of this procedure and reduce the burden of responsibility on women, is evident. From Wall Street trader turned entrepreneur, the story of Signati and Billy’s journey is stacked with insights that are sure to leave you informed and inspired.

Hair loss affects more than 80 million Americans—approximately 50 million men and 30 million women. This market is large and complex, but most importantly, it represents a wide range of patients. For about 25% of American men, the balding process begins in their 20s and almost 85% will experience noticeable hair loss by their 50s. Women, on the other hand, can lose their hair for a variety of reasons ranging from postpartum hormones to menopause.Traditional transplant remedies can be invasive, leaving a linear scar, and incur significant downtime. In contrast, Venus hair restoration equipment provides the right tools for the physician to create a natural-looking hairline for their patients. Joseph ‘Joey’ Brown, Global VP of Venus hair joins this episode to share how they are blending artificial intelligence with robotics to bring a new standard of treatment for patients.As someone who has suffered from hair loss himself, Joey shares honest insights into the mental anxiety faced, and why despite recent advance in hair transplant techniques, the robotic technology available via Venus’s ARTAS system, offers a new elevated level of accuracy and precision not previously seen before in the procedure. With more than 25 years of extensive industry knowledge, combined with Joey’s passion for helping other patients tackle their hair loss condition, this conversation is sure to leave you informed and inspired.

While the U.S. leads in many areas of healthcare innovation, it also lags behind much of the industrialized world in providing care for some of its most vulnerable populations. When it comes to maternal health, March of Dimes reports that a woman dies every 12 hours from pregnancy-related causes, deaths that show huge disparities and could be prevented. As an international leader in healthcare innovation, Philips is investing billions of dollars every year to advance R&D and help tackle health disparities. Jennifer Law, Philips’ recently appointed Maternal Health Leader, joins this episode to share how they are partnering with customers to increase productivity and deliver better care for more mothers across the world.Jennifer shares insights into some of the technology that is shaping improved outcomes, helping to reach people in new places, and with enhanced intelligence. From AI to tele-health solutions, the underpinning factor is an inclusive approach that has a personal touch. Tune in to learn more about how Jennifer is helping guide Philips’ mission in maternal health, a story packed with passion that is sure to leave you informed and inspired.

In this enlightening episode, CEO & co-founder Melody Roberts delves into the often-overlooked topic of stress urinary incontinence (SUI) and its impact on women's lives. SUI, a condition where physical movement or activity causes involuntary leakage of urine, affects millions of women, impacting their confidence and quality of life. Melody breaks down the causes, from childbirth to menopause, and the daily challenges women face, including the stigma and emotional toll associated with the condition.Melody introduces the innovative work being done at Liv Labs, a company dedicated to empowering women through education and novel solutions. She highlights Liv Labs' new coaching service and plans for a comprehensive online education platform, designed to provide women with the knowledge and resources they need to understand and manage SUI. Moreover, you can learn about Liv Labs' development of a cutting-edge pessary solution—a non-invasive device that offers a discreet and effective way to manage symptoms, allowing women to regain control and live their lives without interruption.Join Melody as she shines a light on SUI and shares how Liv Labs is pioneering change, providing hope, and improving the lives of countless women around the world. From their dynamic design duo roots to a mission centered around community, this is a conversation sure to leave you informed and inspired.

Large numbers of people are affected by infertility in their lifetime. According to a new report published today by the World Health Organization, around 17.5% of the adult population – roughly 1 in 6 worldwide – experience infertility, showing the urgent need to increase access to affordable, high-quality fertility care for those in need.The new estimates show limited variation in the prevalence of infertility between regions. The rates are comparable for high-, middle- and low-income countries, indicating that this is a major health challenge globally. Lifetime prevalence was 17.8% in high-income countries and 16.5% in low- and middle-income countries.Joining this episode to share their mission to solve some of the problems couples are facing, is the dynamic duo of Andreia Trigo (CEO) and husband Frank Khan Sullivan (CTO) of Enhanced Fertility. Their platform is bringing a new level of data-driven accessibility to patients from the comfort of their homes. Andreia’s shares how current inadequate systems impacted her own fertility journey, an emotional story that sets the stage for the collaborative program they are providing to deliver better outcomes for couples across the globe.Founders’ stories are often intertwined with personal knowledge of the problem they are looking to solve. From the get-go learning about Andreia’s own experiences, this discussion offers a range of insights into the trials and tribulations that couples are facing through their fertility journeys. Frank shares how their North Star is referred to as Net Baby Score, a measured commitment to help millions of people procreate their families, an incredible mission that is sure to leave you informed and inspired.

Breast cancer is the most commonly occurring cancer in women and the most common cancer overall. Treatment often starts with a surgery known as a lumpectomy to remove the cancer, but in a high % of cases, patients may undergo multiple re-excisions after their procedure in an attempt to obtain clear margins and avoid mastectomy.In this episode, CEO of Dilon Technologies, George Makhoul, shares how they are helping to significantly reduce the need for re-excision with the use of their MarginProbe. A lumpectomy is a challenging surgical procedure, complicated by two obvious yet conflicting priorities: excise as much tissue as necessary to remove the cancer from the breast, remove as little tissue as possible to achieve the best cosmetic result.The MarginProbe System is designed to give today’s surgeons a significant new advantage in margin assessment. In a procedure of roughly five minutes, MarginProbe provides real-time, detailed information to help a surgeon decide whether additional tissue should be taken, or whether to complete the lumpectomy procedure and close the incision.George’s background in marketing gives him a strong edge in the art of communication with stakeholders which shines through as he details the technology’s journey over the past four years. His consummate professionalism in articulating a clear approach and vision, has helped position Dilon as a leader in its field, backed up by some game-changing innovation that can significantly improve the outcomes for patients. With an inspiring mission for creating impact across the globe for women, this discussion will truly leave you informed and inspired.

The rigid, plastic T-shaped intrauterine device (IUD) has been available for over 40 years, with little to no innovation. Insertion is painful and involves numerous painful steps, and removal requires bothersome dangling strings, which are a nuisance for women and their partners. Most importantly, the pain associated with insertion and removal is widely known, leading to a nearly universal fear, particularly among younger women, of selecting an IUD.This ‘fear factor’ is a significant barrier that prevents women from adopting one of the most effective forms of contraception. 3Daughters’ goal is to eliminate this barrier to adoption and radically transform the IUD experience for both practitioners and patients.Mary Beth Cicero, CEO and co-founder of 3Daugthers, joins this episode to share how their innovative design forms a small frameless magnetic IUD that self-assembles in the uterus and conforms to a women’s body – with no strings attached. Through technological and scientific advancements, 3Daughters is addressing the pain and resulting ‘fear factor’ of IUD insertion.Alongside experienced co-founder Shelley Amster, Mary Beth discusses how in just two years the company has already made significant progress to translate their novel approach. With a comprehensive system and high-performance team, there is a belief within that this could be the first billion-dollar women’s health product.Big problems require big vision thinking, and it’s clear through this conversation that this is a team brimming with the passion and perseverance to realize their goals. As a seasoned consultant and marketer, Mary Beth offers some welcome insights as to what it takes to build a solution when those around you might not share the same optimism. #IUD has been trending for the wrong reasons and 3Daughters is on a mission to change the status quo. If you’re ready to be informed and inspired, then listen in.

Transforming the outcomes for a disease takes great innovation. With that, you need impeccable dedication and leadership for the team to deliver on taking a solution to market. Former CEO of LimFlow, Dan Rose, is one such leader who can attest to the trials and tribulations of this challenging journey.Dan joins this episode to share the story of how LimFlow’s technology has gone from an idea with potential, to a life-saving solution. In achieving this, the company has been able to re-design the anatomy of the body to offer hope to those suffering the effects of Chronic Limb-Threatening Ischemia (CLTI).During this discussion you will learn the despairing depths of a disease that is quite literally ravaging people’s lives. Dan shares how he was able to build a world class team from across the globe to design a new option for patients where none existed before. Navigating numerous challenges, raising significant amounts of capital, and leading the company to a successful acquisition by Inari Medical; From beginning to end, this tale will truly leave you informed and inspired.

Research suggests that women are more likely to experience joint pain, aching, and stiffness caused by arthritis or arthritic conditions. In fact, evidence suggests that women aged 50 to 60 years may be 3.5 times (350%) more likely to develop CMC osteoarthritis than men in the same age group.CEO and co-founder of Grace & Able, Sarah Dillingham, is one such arthritis sufferer. Following a life-changing moment, she decided to tackle the lack of suitable relief products for women. Through building an entire support community, Sarah has connected directly with those experiencing arthritis to offer a customized solution for women.The main symptoms of arthritis are joint pain, inflammation, and stiffness, which typically worsen with age. The most common types of arthritis are osteoarthritis and rheumatoid arthritis. Osteoarthritis causes cartilage — the hard, slippery tissue that covers the ends of bones where they form a joint — to break down. Rheumatoid arthritis is an autoimmune disease in which the immune system attacks the joints, beginning with the lining of joints. The main goals of arthritis treatments are to reduce symptoms and improve quality of life.In this episode you will learn what it takes to turn from patient to advocate to brand and product leader. Brand authenticity is something many companies aspire to, Sarah’s genuine and respectful approach with customers to truly understand their needs is something that any entrepreneur could learn from. With this universal design approach, she has been able to create value driven relationships to help grow the business. This is definitely a discussion that will leave you informed and inspired.

What are metamaterials and how can they help improve the performance of MRI?? Step forward Ryan Mcnaughton, CEO and co-founder of Primetaz to reveal how their technology is set to dramatically enhance both the quality of imaging but more importantly, offer game-changing time-saving to a process that is seeing significant growing demand.MRI has become one of the most important tools for doctors to see inside the body to understand what is happening in disease. MRI shows soft tissues like the brain, the heart, and other muscles and organs. It provides several ways to view the status of the tissue, such as looking at the shape, changes to the structure, blood flow, and inflammation. Being able to see inside the body quickly and clearly has led to advanced treatments and longer, healthier lives. Given the every increasing demand for MRI as a flexible imaging technique, many physicians, scientists, and engineers like Ryan continue to develop new ways to see disease earlier, enabling more effective treatments.While sharing the mission & motivation behind Primetaz, Ryan reveals insights that many entrepreneurs will readily relate to as well as detailing a vision that will excite both investors, patients, and physicians alike. Turning from engineer or any technical profession to entrepreneur is always a journey, and Ryan’s dedicated approach is sure to leave you inspired and informed.

Thirona’s CEO and Founder, Eva van Rikxoort, joins this episode to share how their FDA-approved device is now integrating into the clinical workflow to both enhance physician performance and patient outcomes. LungQ is built on more than 10 years of clinical trials and 200+ publications to utilize AI allowing automatic segmentation of pulmonary segments and subsegments found in the internal anatomy of the lung.This clearer understanding of lung anatomy helps enable broader adoption of minimally invasive treatments for lung diseases such as COPD and lung cancer, helping save more healthy lung tissue and lung function capacity. Acting as a map for lung anatomy, LungQ helps guide bronchoscopic navigation, leveraging AI to significantly enhance the precision, accuracy, and efficiency of bronchoscopic and surgical lung interventions.With such emerging AI applications comes a wonderful story of a mission-driven team that is connecting across continents to bring new levels of precision and accuracy to patients. As a scientist turned entrepreneur, Eva demonstrates all the characteristics of a great leader who is building a collaborative model for success. If you’re looking to learn how AI-powered software should be leveraged, then tune in to be informed and inspired.

Breaking bones is unfortunately a common part of life; in fact doctors treat about 6.8 million fractures each year in the United States alone, and the average person can expect to sustain two fractures over their lifetime. In this episode, we are joined by Brian Hess, CEO and Founder of RevBio, who is helping to transform bone repair with their innovative adhesive. Not only is this solution boosting how bones can rapidly fuse back together through its biomimicry properties, this is a product that stimulates bone growth and leaves no artifact in the body.From raising nearly $20 million in non-dilutive funding, it’s clear that this technology has huge potential with multiple indications available to be applied to. Brian lays out a clear strategic path to market that includes the opportunity to leverage early animal studies with veterinarians also seeing significant value from this exciting technology in the near term.Throughout this discussion, Brian displays all the attributes of a great leader, with a top co-founder coupled alongside in Grayson Allen, they have developed a winning culture, and a team that thrives on the opportunities they are given to both develop personally and help take this product to market.As a UMass M2D2 resident, RevBio is able to access a number of resources and an incredible pipeline of young talented interns who have grown with the company and stepped up into more senior roles. This is a startup story that is packed full of the hallmarks for building a successful innovative medical solution, and one that is sure to leave you informed and inspired.

Benign prostatic hyperplasia (BPH), also known as enlarged prostate, has been in the headlines recently with Britain's King Charles revealing plans earlier this year to have a corrective procedure to alleviate the associated symptoms. In this episode, Tushar Sharma, Vivifi Medical’s CEO and Founder, joins us to guide listeners through an amazing anatomical insight of the condition and their novel treatment.An enlarged prostate is a fact of life for the majority of men as they age. Due to the prostate’s close proximity to the urethra which carries urine from the bladder, pressure can build on this vessel as the prostate expands, leading to a range of associated urinary issues. Depending upon the severity of the patient's symptoms, different surgical techniques may be needed to alleviate these, with doctors often considering invasive surgery the best long-term option for relief of more bothersome effects.Under the leadership of Tushar, their exciting solution holds significant promise and despite its early development stage, has already received excellent feedback from surgeons. With such an innovative technology, comes a complex set of product development, clinical, regulatory, and reimbursement challenges. Tushar’s passion for bringing their product to market shines throughout this discussion, and his meticulous manner in solving these challenges is sure to leave you informed and inspired!

Studies show that over 65% of patients with chronic pain, Parkinson's Disease, post-acute stroke, and pelvic floor disorders do not fully recover with current treatments - resulting in hospital readmissions and ER visits. In this episode, we are joined by Siva Nadarajah, co-founder and President of JOGO Health, to share how more than a decade’s worth of research and testing has been undertaken to address this problem through their digital rehabilitation solution. Promising early results have shown how several chronic residual disabilities can be treated via telemedicine using their platform. JOGO helps healthy brain cell networks rewire themselves to work with muscles that have become inactive due to stroke and other neuromuscular conditions. JOGO also helps break the pain-anxiety muscle tension cycle to reduce chronic and cancer pain. The power of neural plasticity is fully leveraged through their novel prescription digital therapeutic product composed of wearable wireless s/EMG sensors. A patent-protected mobile app uses AI and VR to provide treatment protocols and games that can be adapted for muscle relaxation, movement coordination, and neuromuscular re-education. Siva also shares the origin story of the company, including the name “JOGO”, derived from Joe and Gordon - Dr. Joe Brudny and Dr. Gordon Silverman of New York University’s Rusk Rehabilitation Center and Rockefeller University, respectively. Beyond the more recent research, Joe and Gordon established the underlying science more than 50 years ago, and the JOGO platform is now finally rewarding Joe and Gordon's legacy to offer new hope for patients across multiple disease domains. Tune in so you can learn how this pioneering work is drawing together entrepreneurs, product design specialists, technology enthusiasts, physical therapy professionals, physiatrists, data scientists, and game designers, to deliver an effective solution for patients. From democratizing healthcare, to international collaborations for Go-to-Market strategy, this discussion is packed with knowledge to keep you informed and inspired.

The process of trying to conceive can prove to be an emotional rollercoaster – surprise, confusion, anger, worry, rage, sadness… Plus, the burden of having to monitor your body for signs of fertility that previously you'd never paid attention to can also add to the feelings of anxiety and guilt.As many as 8 million women in the US face difficulty when trying to become pregnant. Uros Kuzmanovic, CEO and co-founder of BioSens8, is on a mission to alleviate some of this burden by making tracking hormonal cycles a far easier process with their novel at-home diagnostic tool.Ovulatory dysfunctions are faced by 40% of women, the ability to test hormonal cycles at home will allow far greater control and help avoid the stress and challenges of visiting clinics to provide blood samples to access this data. This enhanced ability to track from the comfort of home, also aims significantly reduce the number of visits during IVF treatment.BioSens8 is a true platform innovation, with multiple opportunities to improve patient experience. Beyond their finger-prick test, there is also exciting technology being developed to allow continuous hormonal monitoring with a wearable device. Naturally, this is attracting the eyes of both patients and IVF clinics who are eager to improve outcomes.Throughout this discussion, Uros details the strength in being scrappy when it comes to building a startup and bringing game-changing innovation to market. From leveraging pitching contests, accelerator programs, and non-dilutive funding, this conversation covers it all. If you’re ready to be inspired and informed then tune in to enjoy this story.

Abdominal cavity examinations can be complex and expensive. This means they are often highly inaccessible for many people. OUI Medical was founded by Dr. Adarsh Patil in 2023 with a singular vision: to revolutionize the way abdominal examinations are conducted. Driven by a passion for innovation and a dedication to excellence, his team has set out to develop a solution that addresses the challenges of traditional diagnostic methods.The current standard involves laparoscopy, a minimally invasive surgical procedure, sometimes referred to as keyhole surgery, as it uses a small incision to gain access to the body. There are currently estimated to be more than 14 million laparoscopic procedures performed annually worldwide, with this number anticipated to grow significantly in the years ahead.Despite this projected growth, the need for general anesthesia in current abdominal procedures makes this a resource intensive operation, placing a burden on healthcare systems. Pressures on Medicare spending, and a lack of access to surgical facilities in many countries, mean there is a strong need for innovation in this space.OUI Medical is pushing the boundaries of medical technology to create products that are not only effective but also accessible and user-friendly. Their initial product, the P-Scope, can be used with a local anesthetic administered, making abdominal diagnostic procedures more efficient, less invasive, and more affordable.From his home base of Bangalore, India, Adarsh has networked to build an engaged team, including a fantastic group of advisors, and truly leverage the ecosystem to help bring the product to market. He is proving that distance should not be a barrier to bringing great innovation to market. If you want to learn more about how this game changing technology could localize access for billions of people, tune in so you can be inspired and informed.

The healthcare landscape is primed and ready for consumers to have better control of their own health. With patients regularly facing significant out of pocket costs for diagnostic testing, combined with a poor user experience in trying to access the healthcare system, Nathalya Mamane, CEO and Founder of RT MicroDx, is stepping forward to leverage technology and provide an improved standard of care.In this episode, we discover how her startup is tackling testing issues head on. The company’s beachhead product is targeting Strep Throat, a common bacterial infection that affects millions of people every year. Despite its frequency, K Health reported that the cost of a strep test in the US averages $270 at a doctor’s office without insurance.RT MicroDx is looking to provide molecular testing from the comfort of your home, to make the test quicker and more efficient, meaning it will be more accessible for patients, leading to a more equitable system for all.As a non-technical founder, Nathalya’s journey is one that can be a shining light for other entrepreneurs looking to make an impact in the medtech space. She is demonstrating that by tapping into the startup ecosystem, and implementing a robust Go-to-Market strategy, it is possible to bring innovative solutions to patients without prior technical experience.Nathalya’s passion for solving a problem faced by millions of people shines through in this discussion. To overcome a challenging fundraising climate, she has preserved and continued to build value through strategic thinking, iterative development, and creating a strong network. This is truly a wonderful conversation with a great founder, so tune in so you can be equally informed and inspired!

Fundraising is a challenging process which is often confusing, drawn out, and ultimately leaves many founders frustrated. Statistics show that for certain founders, there appears to be an additional imbalance which is causing concern across the innovation ecosystem.Despite extensive data showing the benefits of a diverse founding team, underrepresented and underserved founders are still regularly being overlooked when it comes to dollars being distributed to startups.Allison Byers, CEO and Founder of Scroobious, steps forward to share her personal experience from medtech leader, to inspirational diversity fundraising champion. Her mission is to remove unfair, and often unseen bias in the pitching process through a combination of community and data science.Scroobious is leveraging the modern business plan, aka, your pitch deck, to help level the playing field for all founders when it comes to fundraising. Their value-driven platform teaches the top tips when it comes to building your story and conveying the best message to showcase your innovation, all while forging connections with funders too.If you want to learn more about how you can wow with your next investor presentation, or how a 19th Century poem is helping to celebrate and reap the benefits of diversity, then be sure to tune in so you can be equally inspired and informed.

Starting a medical device company is hard. Successfully building a medical device company is even harder. Medtech entrepreneurs are therefore constantly searching for guidance and support on their journey. If you ever wanted a podcast episode to act as a roadmap to accelerate your journey from idea to market, then this is the one for you!Tune in to hear how FastWave Medical is truly making waves when it comes to Intravascular Lithotripsy (IVL). Not only are they bringing exciting new treatments to address an over $10B market in artery calcification, they are doing it in a hyper methodical and rapid manner. Incorporated 3 years ago, the startup went on to raise a $12M Series A round just six months later.The power of a great innovative product, combined with a leading team, shines through in this discussion with CEO and co-founder, Scott Nelson. And speed is a common theme during this episode, as Scott effortlessly translates the complex approach being undertaken with insightful knowledge bombs dropped apace from the get-go!If you want to follow in the footsteps of Scott and his fast-moving team, then be sure to have your pen and paper ready. FastWave is paving the way for other founders, so get ready to be inspired and informed. 

Some of the best technologies developed take their inspiration from the natural environment, and Limax Biosciences is following in this vein, with their novel hydrogel glue seeking to transform how we treat injuries inside and outside the body.Co-founder Ben Freedman steps into this episode’s guest seat to share his mission of putting an end to disruptive and excessive bleeding that creates substantial costs for the healthcare system. With multiple applications for their innovation, significant progress has already been made towards closing the gap on hard to address vascular bleeds.The Limax hydrogel has been shown to be capable of adhering to a bloody and beating pig heart, highlighting the unprecedented strong and flexible adhesion capabilities. Add to this, its biocompatible and antimicrobial features, and you can see why this technology is backed as one to watch by those in the industry.If you want to learn more about the Latin foundation of their solution and expand your knowledge of medtech mimicry then this episode is sure to tick all those boxes and more!

The inspiration behind Samay Health was founder Maria Artunduaga’s abuela, Sylvia. Maria witnessed her grandmother’s struggles to understand when her COPD was exacerbating. After she died, Maria decided to switch careers, so that no one else dies because of misdiagnosis.Maria Artunduaga is a Colombian-born physician-scientist and inventor with 50+ prizes and publications. Her pragmatic approach to building a novel solution is based on both a passionate foundation and recognition that the current standard of care still sees half of discharged COPD patients die within 5 years.During this episode we unpack more of the eye-watering statistics around Chronic Obstructive Pulmonary Disease (COPD) and how Samay is on a mission to move away from subjective survey assessments to an intelligent data-driven respiratory monitoring platform.If you want to know what it takes to tackle one of the world’s leading causes of death, then be sure to tune in to learn more about Maria’s journey so you can be equally inspired and informed.

During this episode we learn how two Georgia Tech graduates came together to form Augment Health and settled on creating a smart bladder monitor for neurological conditions. There are 7 million people who have lost feeling and function of their bladder due to a chronic neurological condition.As two young entrepreneurs, Stephen Kalinsky shares how he and his fellow co-founder took on a number of challenges, pivoted into their innovation, and kept a steadfast mindset to understand the clinician and patient needs they are addressing.It is this patient experience driven approach that has seen Augment making great strides to develop a solution that truly makes a difference for the patient and their care team. Stephen discusses how by immersing in the medtech ecosystem and joining a number of leading programs, they have been able to leverage the full support of the innovation community towards their goals.Recorded in mid-March 2023, this episode is a reminder that the principles of being great founders are timeless and can be applied at any age. Tune in so you can be informed and inspired!

Gitte Pedersen is a Danish scientist and company builder using mRNA to design next generation cures for cancer. Together with her brother, she co-founded Genomic Expression where the familial tale extends into the startup’s origin story.In this episode, co-host @kyle kruse and I discover what led Gitte to tackle the significant issue faced by many cancer sufferers in the world. The lack of specificity that recognized therapeutics provide for cancer, or sometimes, the lack of any available treatment option at all.Genomic’s OneRNA platform enables repurposing existing drugs even on an individual patient basis and the development of novel RNA therapeutics. We learn how the platform is targeting both ends of the spectrum with their first indication, Breast cancer, the most common type of cancer, as well as building studies for rare types where 40,000 or less patients are affected. It's worth highlighting that these rare types account for a quarter of all cancers in the US!As recent applications of mRNA vaccines and AI-driven healthcare solutions have shown, there is finally a possibility for the rapid development of personalized and more effective treatments. This paradigm shift in medicine makes the work of Genomic Expression well worth a listen to learn more about!

We all know how easy it can be to hit your head against something, whether this be a light knock or a more serious collision. However, when it comes to recognizing the difference between the impact of these knocks, it’s not quite as easy!As a nurse practitioner, Debbie Kantor, has witnessed firsthand the issues this can cause. This inspired her to found Hero Medical Technologies and utilize a data-driven approach to improve how we diagnose and monitor TBIs. Hero Medical is developing a more effective bandage to alleviate any associated bleeding, combined with embedded sensor technology that can help identify those key signals that might be missed or delayed in being identified.Added to this innovative medical device, Hero Medical has also created a pain monitoring app that can offer a whole extra layer of patient monitoring from home to further enhance head injury insights. Through this episode Debbie describes the divergent regulatory journeys being embarked upon as they look to make early leverage of TBI data through machine learning while navigating a challenging fundraising landscape.Whether for military applications or monitoring at home, Hero Medical is truly triaging TBI patients with their data science approach. If you want to be equally inspired and informed then be sure to check out the episode!

Tragic moments in life are often the driving force behind big decisions that steer many of the outcomes we experience. For Alexander Colton of Cosmos Pharmaceuticals, he has taken one such moment as the inspiration to take action and help make every pill count.Alexander’s passion for the problem being addressed exudes throughout this high-energy discussion on how Cosmos is tackling one of the biggest little secrets in medical care, the challenges with medication adherence. There’s a reason that clinicians are championing this cause as they see firsthand the ramifications of poor pill management.Step forward, Fortiskap, an intelligent pill cap that is being developed to track and monitor consumption to enable better treatment delivery through superior data intelligence. Beyond their beachhead of helping mental health patients, we delve into the big vision around connected care in the home and the potential for AI to be used as a force for good in remote patient monitoring.As a recent IMPACT accelerator Cohort member, Alexander shines a light on how important it is to embrace the ecosystem and validate your Go-to-Market strategy with patients and physicians. While the wheels of traction are starting to spin, this is the perfect time to learn more about the Cosmos journey so you can strap in for the ride ahead. After winning Life Science Nation’s Most Investable Award, this is definitely one to tune in for!

How do you turn an academic research project into a truly accessible product to help improve or save lives??There’s so much value to unpack from this conversation with Katherine Clayton of OmniVis as she discusses her journey from childhood dreams of curing all diseases, to Phd researcher, turned entrepreneur and startup leader.We touch on how having an inspirational supervisor and other key advisors helped transition from lab work to forging a pathway to commercialize her research, utilizing the much-vaunted customer discovery methodology.Katherine shares insights into the latest product focus and how she has applied the mantra, think global, act local, to undergo a key pivot and leverage her native marketplace. With a huge ambition to solve multiple SDGs and remove food safety issues before they appear on your plate, this is definitely an episode that will whet the appetite of those passionate about solving the big problems!

As we approach the end of Breast Cancer Awareness month, the #MedtechImpactPodcast wanted to shine a light on some exciting innovation which is offering a new level of precision and data driven insights for breast cancer imaging.In our latest episode, Kyle and Richard chat with CEO of DeepLook Medical, Marissa Fayer about how she is driving a collaborative strategy through their software solution. DeepLook’s FDA approved DL Precise is helping radiologists across the treatment pathway (Ultrasound, Mammography, CT, MRI) to automate lesion segmentation and measurement with unprecedented precision - all with a single click.  With breast cancer trending towards 1 in 7 in women, we discuss how a company formed just four years ago, is helping provide the essential data analysis tool to create efficient, accurate, and accessible methods for early detection and diagnosis.As Marissa’s leadership extends far beyond DeepLook, we also discuss her experience in the medtech industry, startup investing, support for female entrepreneurship, and passion for making medical technologies more accessible across the world. Tune in to be informed and inspired!